Harnessing the Power of Multiomics from a Single Sample to Explore Tumor Heterogeneity and Advancing Immuno-Oncology Research
The omics era has greatly expanded the repertoire of approaches available for researchers and clinicians to unravel the complexity behind cancer onset in humans: Next Generation Sequencing (NGS) approaches can characterize genomes, epigenomes, transcriptomes, and proteomes of patient samples. In this poster, we present a workflow to rapidly produce a diverse set of multiomic results from a single blood draw.
Download the poster to discover how advanced DNA barcoding and automated microfluidics can take your research to the next level, enabling multiomic characterization of single cells.